The global cold, cough, and sore throat remedy market is poised for steady growth, with a projected CAGR of 3.40% from 2024 to 2034. The market is estimated to be valued at US$ 42,618.7 million in ...
Experts from Duke Cancer Institute discuss the creation of individualized management plans to transition patients from oncologist to primary care physician. Beyond Cancer: A Multidisciplinary ...
It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations ...
These include analgesics or NSAIDs for pain, decongestants, expectorants, antihistamines or cough suppressants, the experts noted. “A lot of cold products have a lot of these combined together ...